Resistencia intrínseca de Haemophilus influenzae a los betalactámicos

Medicina Clinica

Volumn 110, Issue SUPPL. 1, 1998, Pages 52-59

  Rodríguez Avial, Carmen ^a   Váñez, Rosa ^a   Rodríguez Avial, Icíar ^a   Picazo, Juan J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFACLOR; CEFOTAXIME; CEFUROXIME; PENICILLIN BINDING PROTEIN;

ANTIBIOTIC RESISTANCE; EUROPE; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NORTH AMERICA; PREVALENCE; REVIEW; ARTICLE; BACTERIAL INFECTION; DRUG EFFECT; HUMAN;

BETA-LACTAM RESISTANCE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS;

EID: 0031892760     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Khan W, Ross S, Rodríguez W, Controni G, Saz AK, Haemophilus influenzae type b resistant to ampicillin. J Am Med Asoc 1974; 229: 298-301.
2. Williams JD, Kattan S, Savanagn P. Penicillinase pruduction by H. influenzae. Lancet 1974; 2: 103.
3. Bell SM, Plowmaen D. Mechanisms of ampicillin resistance in H. influenzae from respiratory tract. Lancet 1980; 1: 279-280
4. Markowitz SM. Isolation of an ampicillin-resistant, non beta-laclamase producing strain of H. influenzae. Antimicrob Agents Chemother 1980; 17: 80-83.
5. Offit PA, Campos JM, Plotkin SA. Ampicillir-resistant β-lactamase negative H. influenzae type b. Pediatrics 1982; 69: 230-231.
6. Rodriguez-Avial C, Martinez Redondo P, López Bartolomé O et al. Cepas de H. influenzae resistertes a ampicilina y no productoras de betalactamasa. Infectológika 1984; 4: 11-17
7. Malouin F, Bryan LE. Modification of penicillin-binding-proleins as mechanisms of β-lactam resistance. Antimicrob Agents Chemother 1986; 30: 1-5.
8. Parr TR, Bryan LE. Mechanism of resistance of an ampicilin-resistant, β-lactamase negative clinical isolate of H. influenzae type b to β-lactamantibiotics. Antimicrob Agents Chemother 1984; 25: 747-753
9. Mendelrnan PM, Chaffin DO, Stull TL, Rubens CE, Mack HD, Smith AL. et al. Characterization of non β-lactamase mediated ampicillin resistance in H. influenzae. Antimicrob Agents Chemother 1984; 26: 235-244.
10. Mendelman PM, Chaffin DO, Musser JM, De Groot R, Serfass DA, Selandor RK et al Genetic and phenotypic diversity among ampicillin-resistant, non β-lactamase producing nontypeable, H. influenzae isolates. Infect Immur 1987; 55: 2.585-2.589
11. Serlass DA, Mendelman PM, Chaffin DO, Needlam CA. Ampicillin resistance and penicillin binding proteins of H. influenzas. J Gen Microbiol 1986; 132: 2.855-2.861.
12. Burns JL, Smith AL. A major outer-membrane protein funtions as a porin in H. influenzae. J Gen Microbiol 1987; 133: 1.273-1.277
13. Philpott-Howard J, Williams JD. Increase in antibiotic resistance in H. influenzae in the United Kingdom since 1977: report of a study group. Br Meet J 1982; 284: 1.597-1.599.
14. Powell M. Antimicrobial resistance H. influenzae. J Med Microbiol 1988; 27: 81-87.
15. Machka K, Braveny I, Dabernet H, Dombush K, Van Dyck E, Kayren FH et al. Distribution and resistance patterns of H. influenzae: a European cooperative study. Eur J Clin Microbiol Infect Dis 1988; 7: 14-24.
16. Kayser FH, Morenzoni G, Santanam P. The Second European Collaborative study on the frecuency of antimicrobial resistance in H. influenzae. Eur J Clin Microbiol infect Dis 1990; 9: 810-817.
17. Williams JD, Powell M, Fan YS, Seymour A, Yuan M. In vitro susceptibility of H. influenzae to cefaclor, cefixime, cefetarnet and loracarbet. Eur J Clin Microbiol Infect Dis 1992; 11: 748-751.
18. Cullman W. Comparative evaluation of orally active antibiotics against community-acquired pathogens: results of eight european countries. Chemotherapy 1996; 42: 11-20.
19. Perea EJ, Garcia MC, Clavijo MJ, Piedrola G, Campos J, Garcia Rodriguez JA et al. Resistencias en H. influenzae en Espan̄a. Segundo estudio (1990). Enferm Infecc Microbiol Clin 1993; 11: 19-28.
20. Doern GV, Jorgensen JH, Thormsberry C, Preston CA, Tubert T, Redding JS et al. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of H. influenzae. Antimicrob Agents Chemother 1988; 32: 180-185.
21. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of H influenzae. M. catharralis and S. pneumoniae in the United States. Antimicrob Agents Chemother 1990; 34: 2.075-2.080
22. Clairoux N, Picard M, Brochu A, Rousseau N, Gourde P, Beauchamp D et al. Molecular basis of the non-β lactamase mediated resistance to β-lactam antibiotics in strains of H. influenzae isolated in Canada. Antimicreb Agents Chemother 1992; 36: 1.504-1.513
23. Doern GV. Antimicrobial resistance among lower respiratory tract isolates of H. influerzae: results of a 1992-1993 western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group. J Antimicrob Chemother 1996; 38 (Supl): 59-69.
24. James PA, Lewis DA, Jordens JZ, Cribb J, Dawsor SJ, Munay SA. The incidence and epidemiology of betalactam resistance in H. influenzae. J Antimicrob Chemother 1996; 37: 737-746.
25. Corkill JE, Dove W. Non-enzime mediated β-lactam resistance in H. influenzae. J Anlimicrob Chemother 1996; 38: 1.109-1.111.
26. Fuchs PC, Barry AL. Interpetive criteria for susceptibilities of H. influenzae to ampicillin, amoxicillin and amoxicillin-clavulanic acid. J Clin Microbiol 1994; 32: 2.846-2.850.
27. Mendelman PM. In vitro activities and targets of three Cephem antibiotics aganist H. influenzae. Antimicrob Agents Chemother 1989; 33: 1.878-1.882.
28. Powell M, Livermore DM. Selection and transformation of no β-lactamase-mediated insusceptibility to betalactams in H. influenzae: lack of cross-resistance between carbapenems and other agents. J Antimicrob Chemother 1990; 26: 741-747.
29. Jorgensen JH, Doern GV, Thernsberry O. Susceptibility of multiple resistant. H. influenzae to newer antimicrobial agents. Diagn Microb Infect Dis 1988; 9: 27-32.
30. Powell M, Williams JD. In vitro activity of cefaclor, cefrhalexin and ampicillin against 2.458 clinical isolates of H. influenzae. J Antimicrob Chemother 1988; 21: 27-31.
31. a generación. Barcelona: V Congreso SEIM, 1992.
32. James PA, Hossain FK, Lewis DA, White DG. β-lactam susceptibility of H. influenzae strains showing reduced susceptibility to cefuroxime. J Antimicrob Chemother 1993; 32: 239-246.
33. Barry AL, Fuchs PC, Pfaller MA. Susceptibilities of β-lactamase-producing and non-producing ampicillin resistant strains of H. influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime and amoxicillin-clavulanic acid. Antimicrob Agents Chemother 1993; 37: 14-18.
34. Yeo SF, Chiev YJ, Fung CP. Susceptibility of H. influenzae isolates with known resistance mechanisms to five cephalosporins. Chemotherapy 1996; 42: 85-89
35. Doern GV, Brueggemann AB, Pierce G, Holley HP Jr, Rand A et al. Antibiotic resistance among clinical isolates of H. influenzae in the Unites States in 1994 and 1995 and detection of betalactamase-positive strains resistant to amoxicillin-clavulanate: results of a National Multicenter Surveillance Study. Antimicrob Agents Chemother 1997; 41: 292-297.
36. Picazo JJ, Rodríguez-Avial C. Haemophilus influenzae y Moraxella catarrhalis trente a los antimicrobianos de administración oral. Enferm Infecc Microbiol Clin 1993; 11 (Supl 1): 10-14.